Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000745

Director sold 5,512 shares at an average $17.51 ($96,491)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-07-31 Sale : show line 1 in the form −5,248 $17.51 $91,871 2,277,086 I
2017-08-01 Sale : show line 2 in the form −264 $17.50 $4,620 2,276,822 I
Open-market sales · 5,512 sh · avg $17.51 · $96,491
Loading xslF345X03/vonemster_fm4jul312017.xml…